Home > Journals > Minerva Respiratory Medicine > Past Issues > Minerva Pneumologica 2005 September;44(3) > Minerva Pneumologica 2005 September;44(3):103-22

CURRENT ISSUE
 

JOURNAL TOOLS

Publishing options
eTOC
To subscribe
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Reprints
Permissions
Share

 

REVIEWS   

Minerva Pneumologica 2005 September;44(3):103-22

Copyright © 2005 EDIZIONI MINERVA MEDICA

language: English

Transplantation and noninvasive positive pressure ventilation in chronic obstructive pulmonary disease

Criner G. J., Patel N.


PDF


Noninvasive positive pressure ventilation (NPPV) and lung transplantation both have important places in the management of patients with severe chronic obstructive pulmonary disease (COPD) refractory to medical treatment. Over the past decade, NPPV has taken a central role in the treatment of patients that present with acute respiratory failure complicating COPD exacerbation. COPD provokes a marked reduction in quality of life, secondary to severe airflow obstruction, hyperinflation, and limited exercise tolerance. Lung transplantation is a surgical option for patients who fail optimization of medical treatment for the severe symptoms that result from COPD. This review will discuss the current roles, indications, contraindications, and efficacy of the above 2 treatments in the appropriate COPD patient sub-groups.

top of page